Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$123.81
+2.7%
$132.98
$99.92
$141.23
$215.17B0.736.22 million shs19.57 million shs
Accuray Incorporated stock logo
ARAY
Accuray
$1.34
-1.8%
$1.43
$1.14
$2.95
$137.52M1.26778,385 shs953,047 shs
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$1.10
+0.9%
$0.98
$0.78
$5.15
$37.59M1.57444,989 shs243,735 shs
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
$3.18
+11.6%
$3.65
$2.23
$323.35
$7.59M1.16802,336 shs677,944 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
+2.53%-6.17%-6.45%-5.49%+18.24%
Accuray Incorporated stock logo
ARAY
Accuray
-1.84%-1.84%+8.54%-9.80%-31.54%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
+0.92%-2.65%+17.02%+6.80%-45.68%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
+11.58%+33.61%+24.22%-58.93%-99.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9909 of 5 stars
3.45.04.24.53.72.52.5
Accuray Incorporated stock logo
ARAY
Accuray
2.2079 of 5 stars
0.03.00.04.60.61.71.9
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.6061 of 5 stars
3.73.00.04.10.60.80.0
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.1692 of 5 stars
0.04.00.00.00.60.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.87
Moderate Buy$144.4716.69% Upside
Accuray Incorporated stock logo
ARAY
Accuray
0.00
N/AN/AN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.33
Buy$4.00263.64% Upside
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RMTI, ARAY, RSLS, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$147.00 ➝ $142.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$142.00 ➝ $141.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$148.00 ➝ $145.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$143.00 ➝ $145.00
7/17/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$130.00 ➝ $140.00
7/15/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$145.00 ➝ $147.00
7/15/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$127.00 ➝ $137.00
7/8/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$140.00 ➝ $145.00
6/16/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
(Data available from 7/19/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.13$6.59 per share18.79$27.62 per share4.48
Accuray Incorporated stock logo
ARAY
Accuray
$446.55M0.31N/AN/A$0.45 per share2.97
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
$101.49M0.37$0.13 per share8.70$1.01 per share1.09
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
$8.01M0.95N/AN/A($8.66) per share-0.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.7115.5221.612.3532.43%18.83%10.88%N/A
Accuray Incorporated stock logo
ARAY
Accuray
-$15.55MN/A0.0011.13N/A0.14%1.43%0.14%8/13/2025 (Estimated)
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$480KN/A0.00N/AN/A-0.27%-0.90%-0.47%8/14/2025 (Estimated)
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
-$7.13M-$193.23N/AN/A-48.26%-251.90%-59.49%8/13/2025 (Estimated)

Latest RMTI, ARAY, RSLS, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$0.05N/AN/AN/AN/AN/A
8/13/2025Q4 2025
Accuray Incorporated stock logo
ARAY
Accuray
$0.03N/AN/AN/A$123.78 millionN/A
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.26$1.26N/A$1.01$11.01 billion$11.14 billion
5/20/2025Q1 2025
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/A$18.98N/A$18.98N/A$1.11 million
5/12/2025Q1 2025
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
-$0.03-$0.04-$0.01-$0.04$17.46 million$18.91 million
4/30/2025Q3 2025
Accuray Incorporated stock logo
ARAY
Accuray
-$0.05-$0.01+$0.04-$0.01$101.53 million$113.24 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.91%N/A30.61%54 Years
Accuray Incorporated stock logo
ARAY
Accuray
N/AN/AN/AN/AN/A
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
N/AN/AN/AN/AN/A
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/AN/AN/AN/AN/A

Latest RMTI, ARAY, RSLS, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/13/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.73%7/15/20257/15/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.26
1.78
1.27
Accuray Incorporated stock logo
ARAY
Accuray
3.35
1.64
0.92
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
0.30
2.95
2.50
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/A
1.53
0.91

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Accuray Incorporated stock logo
ARAY
Accuray
64.08%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
23.31%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
22.06%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Accuray Incorporated stock logo
ARAY
Accuray
4.23%
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
3.60%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
Accuray Incorporated stock logo
ARAY
Accuray
1,040103.01 million98.66 millionOptionable
Rockwell Medical, Inc. stock logo
RMTI
Rockwell Medical
30034.17 million32.95 millionOptionable
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
502.39 million2.39 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$123.81 +3.30 (+2.74%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$123.80 -0.01 (-0.01%)
As of 07/18/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Accuray stock logo

Accuray NASDAQ:ARAY

$1.34 -0.03 (-1.84%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.38 +0.04 (+3.00%)
As of 07/18/2025 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Rockwell Medical stock logo

Rockwell Medical NASDAQ:RMTI

$1.10 +0.01 (+0.92%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$1.12 +0.01 (+1.36%)
As of 07/18/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

ReShape Lifesciences stock logo

ReShape Lifesciences NASDAQ:RSLS

$3.18 +0.33 (+11.58%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$3.12 -0.06 (-1.73%)
As of 07/18/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California.